An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Van Der Putt R, Thompson S, Manohar SG, Frangou E, Love S, McShane R, Husain M.
Sen A, et al. Among authors: galloway j.
Trials. 2021 Jul 31;22(1):508. doi: 10.1186/s13063-021-05404-4.
Trials. 2021.
PMID: 34332638
Free PMC article.
Clinical Trial.